TickerFactsScreenerDevelopers

Edwards Lifesciences Corp (EW) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2007: $141.80M2008: $218.70M2009: $334.10M2010: $396.10M2011: $171.20M2012: $310.90M2013: $420.40M2014: $653.80M2015: $718.40M2016: $930.10M2017: $818.30M2018: $714.10M2019: $1.18B2020: $1.18B2021: $862.80M2022: $769.00M2023: $1.13B2024: $3.05B2025: $2.94B$2.94B
2007Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$2.94B-3.5%
2024$3.05B+168.9%
2023$1.13B+47.2%
2022$769.00M-10.9%
2021$862.80M-27.1%
2020$1.18B+0.3%
2019$1.18B+65.1%
2018$714.10M-12.7%
2017$818.30M-12.0%
2016$930.10M+29.5%
2015$718.40M+9.9%
2014$653.80M+55.5%
2013$420.40M+35.2%
2012$310.90M+81.6%
2011$171.20M-56.8%
2010$396.10M+18.6%
2009$334.10M+52.8%
2008$218.70M+54.2%
2007$141.80M—